Vident Advisory’s Twist Bioscience TWST Stock Holding History

Vident Advisory’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$429K	Sell	4,171 -143	-3%	-$9.3K	﹤0.01%	1445
2026 Q1	$205K	Buy	+4,314	New	+$193K	﹤0.01%	1694
2025 Q3	–	Sell	-6,920	Closed	-$255K	–	1737
2025 Q2	$255K	Sell	6,920 -1,263	-15%	-$43.6K	﹤0.01%	1381
2025 Q1	$321K	Sell	8,183 -467	-5%	-$21K	﹤0.01%	1248
2024 Q4	$402K	Sell	8,650 -3,124	-27%	-$141K	0.01%	1057
2024 Q3	$532K	Sell	11,774 -4,665	-28%	-$222K	0.01%	887
2024 Q2	$810K	Buy	16,439 +744	+5%	+$30.3K	0.02%	672
2024 Q1	$538K	Buy	15,695 +4,730	+43%	+$171K	0.01%	795
2023 Q4	$404K	Sell	10,965 -4,862	-31%	-$112K	0.01%	872
2023 Q3	$321K	Buy	+15,827	New	+$348K	0.01%	871

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Vident Advisory's TWST Position: Q2 2026 in Review

Vident Advisory reduced its Twist Bioscience (TWST) stake by 3.3% in Q2 2026, selling an estimated $9.3K and leaving 4,171 shares worth $429K. The position accounts for ﹤0.01% of the portfolio, ranked #1445.

Vident Advisory first reported a position in TWST in Q3 2023 and has held it in 10 quarters since. The position peaked at $810K in Q2 2024. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Vident Advisory held 4,171 shares of Twist Bioscience worth $429K as of Q2 2026.
Vident Advisory sold 143 Twist Bioscience shares in Q2 2026, an estimated $9.3K.
Twist Bioscience made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1445 holding.
Vident Advisory first reported a position in Twist Bioscience in Q3 2023 and has held it in 10 quarters since.
Vident Advisory's Twist Bioscience position peaked at $810K in Q2 2024.
337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.